Skip to content

Clinical trials

Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: Germany Clear all

580 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20037
20048
200515
200619
200723
200817
200924
201024
201127
201223
201326
201426
201524
201629
201728
201835
201937
202035
202127
202233
202325
202422
202522
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed299
Recruiting81
Terminated73
Active, not recruiting66
Unknown status48
Withdrawn5
Not yet recruiting3
Enrolling by invitation3
Suspended1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie36
Novartis Pharmaceuticals28
Bayer26
AstraZeneca19
Amgen17
Charite University, Berlin, Germany16
GlaxoSmithKline13
Hoffmann-La Roche13
University Hospital Heidelberg12
Pfizer10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms580
Neoplasm Metastasis60
Breast Neoplasms43
Carcinoma, Non-Small-Cell Lung42
Recurrence35
Colorectal Neoplasms33
Melanoma29
Neoplasms by Site26
Lung Neoplasms24
Ovarian Neoplasms22

Trials

Showing 51 to 75 of 580. Each trial links to its page on Pharma Observatory.

480 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.